Catalyst Wire Dossier Catalyst Wire Dossier

Valneva Chikungunya vaccine candidate (live-attenuated)

· Valneva Austria GmbH
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Valneva Chikungunya vaccine candidate (live-attenuated), covering 2022-07-25 to 2022-07-25. Get the full timeline:

Most recent: Clinical Trial Update: Pivotal Study to Evaluate Safety and Immunogenicity of a Live-Attenuated Chikungunya Virus Vaccine Candidate in Adults [Phase 3]

See pricing